NEW YORK (GenomeWeb News) – Following yesterday's announcement that it had sold one of its Helicos Genetic Analysis Systems to an undisclosed biotechnology company, shares of Helicos BioSciences today traded above $1 per share for the first time in six months.

The Cambridge, Mass.-based firm thus far has announced instrument placements or orders at Stanford University, the Broad Institute, the Dana-Farber Cancer Institute, and the University of Maryland. But this new sale would be the first that it has disclosed for a commercial entity.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

UCSF researchers find that having two X chromosomes may contribute to women's longer lifespans, according to Discover's D-brief blog.

In PNAS this week: immune cell profiling of wild baboons by social status, metabolomics profiling of esophageal tumors, and more.

A genomic analysis of modern and ancient maize reveals a complicated domestication history, according to Reuters.

In PLOS this week: MYRF variant linked to congenital diaphragmatic hernia, analysis of the "dragon's blood" red resin produced by traditional medicine plants, and more.